Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women

Menopause

Volumn 16, Issue 5, 2009, Pages 877-882

  Bachmann, Gloria A ^a   Schaefers, Matthias ^b   Uddin, Alkaz ^c   Utian, Wuif H ^d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b BAYER PHARMA AG   (Germany)

^c Bayer HealthCare Pharmaceuticals Inc   (United States)

^d Rapid Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS LEVONORGESTREL; ESTROGEN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOT FLUSH; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PH; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL PATCH; VAGINA ATROPHY; VAGINA PH; VULVA; VULVAR ATROPHY; VULVOVAGINAL DISEASE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANALYSIS OF VARIANCE; ATROPHY; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LEVONORGESTREL; MIDDLE AGED; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; VAGINA; VULVA;

EID: 73349084620     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181a15606     Document Type: Article

References (14)

1. The North American. Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position, statement of The North. American. Menopause Society. Menopause 2007; 14:355-369.
2. Bachmann GA, Ebert GA, Burd ID. Vulvovaginal complaints. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Philadelphia, PA: Lippincott Williams & Wilkins, 1999:195-201.
3. Gorodeski GI. Vaginal-cervical epithelial permeability decreases after menopause. Fertil Steril 2001; 76:753-761.
4. Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993; 72:286-291. (Pubitemid 23265626)
5. Roy S, Caillouette JC, Roy T, Faden JS. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 2004; 190:1272-1277. (Pubitemid 38692208)
6. The North American. Menopause Society. Estrogen, and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008; 15:584-602.
7. Bachmann GA, Schaefers M, Uddin A, Utian WH. Lowest effective transdermal 17β-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial, Obstet Gynecol 2007; 110:771-779. (Pubitemid 47508739)
8. National Institutes of Health, State-of-the-Science Conference Statement on management of menopause-related symptoms. Ann Intern Med 2005; 142(12 Pt 1): 1003-1013.
9. Skouby SO, Al-Azzawi F, Barlow D, et al. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas 2005; 51:8-14.
10. International Menopause Society. Recommendations on postmenopausal hormone therapy, February 27, 2007. [Update to the original IMS Position Statement in Climacteric 2004; 7:8-11]. Available at: http://www.imsociety.org. Accessed April 16, 2007.
11. British Menopause Society. Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy. Available at: http://www.thebms.org.uk/statementconten. php?id-l#. Accessed April 16, 2007.
12. Center for Drug Evaluation and Research, Guidance for Industry: Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptomsand Vulvar and Vaginal Atrophy Symptoms-Recommendations for Clinical Evaluation. Rockville, MD: U. S. Department of Health and Human Services, Food and Drug Administration, 2003.
13. Ettinger B, Ensrud KE, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004; 104:443-451. (Pubitemid 40458828)
14. Notelovitz M, Funk S, Nanavati N, Mazzeo M. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 2002; 99:556-562. (Pubitemid 34246288)